Vaccine Program Could Spawn Opportunities For Researchers

A report released last month by the Institute of Medicine (IOM) proposes the creation of a National Vaccine Authority (NVA) to oversee the entire process of vaccine research and development in the United States. The authority will also act as a liaison between the federal government and private industry for vaccine production. The report discusses, among other topics, the role of applied research in the development of new or improved vaccines against such diseases as tetanus and cholera both

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The report discusses, among other topics, the role of applied research in the development of new or improved vaccines against such diseases as tetanus and cholera both in the United States and internationally.

Though the report does not directly address expanded vaccine research opportunities under the proposed authority, Violaine Mitchell, the study director at IOM, says investigators may be attracted to a more directed approach.

"In terms of funding streams it might help direct attention to areas of top priority and attract new researchers there," she says. "On the other hand, so much of what science does well is allowing investigator-initiated research to explore new opportunities."

The report, entitled The Children's Vaccine Initiative: Achieving The Vision (Washington, D.C., National Academy Press, 1993), was produced by an 18-person committee whose members represent academia, industry, government, and nonprofit groups. The committee met on a regular basis between February 1992 and February 1993 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ron Kaufman

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences